146 related articles for article (PubMed ID: 37529004)
1. Cancer testis antigen PASD1 expression and immunogenicity in human colorectal cancer and polyps.
Sukor NF; Yahaya A; Sagap I; Jamal R; Johdi NA
Turk J Biol; 2022; 46(5):361-374. PubMed ID: 37529004
[TBL] [Abstract][Full Text] [Related]
2. CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Cabes M; Lawrie CH; Moir D; Hatton C; Banham AH; Pulford K
Haematologica; 2011 Jan; 96(1):78-86. PubMed ID: 20851862
[TBL] [Abstract][Full Text] [Related]
3. Validation of immunogenic PASD1 peptides against HLA-A*24:02 colorectal cancer.
Soh JE; Abu N; Sagap I; Mazlan L; Yahaya A; Mustangin M; Khoo TS; Saidin S; Ishak M; Ab Mutalib NS; Jamal R
Immunotherapy; 2019 Oct; 11(14):1205-1219. PubMed ID: 31478431
[TBL] [Abstract][Full Text] [Related]
4. Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Lawrie C; Moir D; Hatton C; Banham AH; Pulford K
Br J Haematol; 2009 Aug; 146(4):396-407. PubMed ID: 19552722
[TBL] [Abstract][Full Text] [Related]
5. Infrequent Expression of the Cancer-Testis Antigen, PASD1, in Ovarian Cancer.
Khan G; Brooks SE; Mills KI; Guinn BA
Biomark Cancer; 2015; 7():31-8. PubMed ID: 26327782
[TBL] [Abstract][Full Text] [Related]
6. A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.
Liggins AP; Brown PJ; Asker K; Pulford K; Banham AH
Br J Cancer; 2004 Jul; 91(1):141-9. PubMed ID: 15162151
[TBL] [Abstract][Full Text] [Related]
7. An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.
Hardwick N; Buchan S; Ingram W; Khan G; Vittes G; Rice J; Pulford K; Mufti G; Stevenson F; Guinn BA
Cancer Immun; 2013; 13():16. PubMed ID: 23882161
[TBL] [Abstract][Full Text] [Related]
8. PAS Domain Containing Repressor 1 (PASD1) Promotes Glioma Cell Proliferation Through Inhibiting Apoptosis In Vitro.
Li R; Guo M; Song L
Med Sci Monit; 2019 Sep; 25():6955-6964. PubMed ID: 31558691
[TBL] [Abstract][Full Text] [Related]
9. Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters.
Luo B; Yun X; Fan R; Lin YD; He SJ; Zhang QM; Mo FR; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2013; 6(12):2835-45. PubMed ID: 24294369
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
Joseph-Pietras D; Gao Y; Zojer N; Ait-Tahar K; Banham AH; Pulford K; Rice J; Savelyeva N; Sahota SS
Leukemia; 2010 Nov; 24(11):1951-9. PubMed ID: 20861911
[TBL] [Abstract][Full Text] [Related]
11. Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
Guinn BA; Bland EA; Lodi U; Liggins AP; Tobal K; Petters S; Wells JW; Banham AH; Mufti GJ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1293-304. PubMed ID: 16112646
[TBL] [Abstract][Full Text] [Related]
12. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
13. Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.
Shantha Kumara H; Kirchoff D; Caballero OL; Su T; Ahmed A; Herath SA; Njoh L; Cekic V; Simpson AJ; Cordon-Cardo C; Whelan RL
Oncoscience; 2015; 2(6):607-14. PubMed ID: 26244168
[TBL] [Abstract][Full Text] [Related]
14. PASD1 promotes STAT3 activity and tumor growth by inhibiting TC45-mediated dephosphorylation of STAT3 in the nucleus.
Xu ZS; Zhang HX; Zhang YL; Liu TT; Ran Y; Chen LT; Wang YY; Shu HB
J Mol Cell Biol; 2016 Jun; 8(3):221-31. PubMed ID: 26892021
[TBL] [Abstract][Full Text] [Related]
15. Identification of two new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from colorectal carcinoma-associated antigen PLAC1/CP1.
Liu F; Zhang H; Shen D; Wang S; Ye Y; Chen H; Pang X; Song Q; He P
J Gastroenterol; 2014 Mar; 49(3):419-26. PubMed ID: 23604623
[TBL] [Abstract][Full Text] [Related]
16. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
17. Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.
Li YY; Wang XY; Li Y; Wang XM; Liao J; Wang YZ; Hong H; Yi W; Chen J
Cell Oncol (Dordr); 2023 Jun; 46(3):777-791. PubMed ID: 36920728
[TBL] [Abstract][Full Text] [Related]
18. Critical Role of p53 and K-ras in the Diagnosis of Early Colorectal Cancer: a One-year, Single-center Analysis.
Lu HY; Lin RT; Zhou GX; Yu TM; Liu ZJ
Int J Med Sci; 2017; 14(11):1154-1162. PubMed ID: 29104470
[No Abstract] [Full Text] [Related]
19. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of carcinoembryonic antigen combined with cytokines in serum of patients with colorectal cancer.
Ma Y; Zhang Y; Bi Y; He L; Li D; Wang D; Wang M; Wang X
Medicine (Baltimore); 2022 Sep; 101(37):e30787. PubMed ID: 36123861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
